OUCAGS, University of Oxford, Oxford, UK
Emergency Department, St Mary's Hospital Foundation Trust, London, UK.
BMJ Mil Health. 2020 Jun;166(3):194-200. doi: 10.1136/jramc-2018-001066. Epub 2019 Feb 2.
Haemorrhage is one of the leading causes of battlefield and prehospital death. Haemostatic dressings are an effective method of limiting the extent of bleeding and are used by military forces extensively. A systematic review was conducted with the aim of collating the evidence on current haemostatic products and to assess whether one product was more effective than others.
A systematic search and assessment of the literature was conducted using 13 health research databases including MEDLINE and CINAHL, and a grey literature search. Two assessors independently screened the studies for eligibility and quality. English language studies using current-generation haemostatic dressings were included. Surgical studies, studies that did not include survival, initial haemostasis or rebleeding and those investigating products without prehospital potential were excluded.
232 studies were initially found and, after applying exclusion criteria, 42 were included in the review. These studies included 31 animal studies and 11 clinical studies. The outcomes assessed were subject survival, initial haemostasis and rebleeding. A number of products were shown to be effective in stopping haemorrhage, with Celox, QuikClot Combat Gauze and HemCon being the most commonly used, and with no demonstrable difference in effectiveness.
There was a lack of high-quality clinical evidence with the majority of studies being conducted using a swine haemorrhage model. Iterations of three haemostatic dressings, Celox, HemCon and QuikClot, dominated the studies, probably because of their use by international military forces and all were shown to be effective in the arrest of haemorrhage.
出血是战场和院前死亡的主要原因之一。止血敷料是限制出血范围的有效方法,被军队广泛使用。本系统评价旨在整理关于当前止血产品的证据,并评估是否有一种产品比其他产品更有效。
使用 13 个健康研究数据库(包括 MEDLINE 和 CINAHL)和灰色文献搜索,对文献进行了系统搜索和评估。两名评估员独立筛选研究的合格性和质量。纳入使用新一代止血敷料的英语语言研究。排除外科研究、不包括生存、初始止血或再出血以及研究无院前潜力的产品的研究。
最初发现 232 项研究,应用排除标准后,有 42 项研究纳入综述。这些研究包括 31 项动物研究和 11 项临床研究。评估的结果是受试者的生存、初始止血和再出血。一些产品被证明能有效地止血,其中 Celox、QuikClot Combat Gauze 和 HemCon 是最常用的产品,其有效性没有明显差异。
高质量的临床证据缺乏,大多数研究都是在猪出血模型上进行的。迭代的三种止血敷料,Celox、HemCon 和 QuikClot,主导了这些研究,可能是因为它们被国际军队使用,并且都被证明在止血方面是有效的。